ATCT-09IDH1 R132H MUTATIONS IN NRG ONCOLOGY/RTOG 9802: PHASE III STUDY OF RADIATION THERAPY (RT) ALONE VS RT PLUS PROCARBAZINE, CCNU, AND VINCRISTINE (PCV) IN PATIENTS WITH LOW GRADE GLIOMA (LGG) Article

Buckner, Jan, Shaw, Edward, Pugh, Stephanie et al. (2015). ATCT-09IDH1 R132H MUTATIONS IN NRG ONCOLOGY/RTOG 9802: PHASE III STUDY OF RADIATION THERAPY (RT) ALONE VS RT PLUS PROCARBAZINE, CCNU, AND VINCRISTINE (PCV) IN PATIENTS WITH LOW GRADE GLIOMA (LGG) . NEURO-ONCOLOGY, 17(suppl_5), v3-v3. 10.1093/neuonc/nov206.09

cited authors

  • Buckner, Jan; Shaw, Edward; Pugh, Stephanie; Gilbert, Mark; Barger, Geoffrey; Coons, Stephen; Ricci, Peter; Bullard, Dennis; Brown, Paul; Stelzer, Keith; Brachman, David; Suh, John; Schultz, Christopher; Bahary, Jean-Paul; Fisher, Barbara; Kim, Harold; Murtha, Albert; Bell, Erica; Won, Minhee; Mehta, Minesh; Curran, Walter; Chakravarti, Arnab

authors

publication date

  • November 1, 2015

published in

keywords

  • 32 Biomedical and Clinical Sciences
  • 3211 Oncology and Carcinogenesis

Digital Object Identifier (DOI)

publisher

  • Oxford University Press (OUP)

start page

  • v3

end page

  • v3

volume

  • 17

issue

  • suppl_5